NSE / BSEHealthcare
β‚Ή347.30-0.20-0.06%
P/E82.7Mkt Capβ‚Ή3.31 K CrEV/EBITDA89.0

Medi Assist Healthcare Services Limited

P/E82.7Mkt Capβ‚Ή3.31 K CrEV/EBITDA89.0
Company Profile

Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. The company offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector. It also provides; and policy administration services to governments to enable public health schemes. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
β€”
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–Ό 33.86% over 1Y
Monthly Returns

Historically, Sep has averaged the highest return (+7.4%); Nov the lowest (-10.3%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-13.2%Negative MonthJan 2026: -13.24%-7.1%Negative MonthFeb 2026: -7.11%-19.9%Negative MonthMar 2026: -19.87%+16.3%Positive MonthApr 2026: +16.25%+8.1%Positive MonthMay 2026: +8.05%-2.0%Neutral MonthJun 2026: -1.97%-5.0%*Negative MonthJul 2026: -5.01%β€”β€”β€”β€”β€”
2025-0.4%Neutral MonthJan 2025: -0.35%-21.5%Negative MonthFeb 2025: -21.51%+0.6%Neutral MonthMar 2025: +0.58%-1.4%Neutral MonthApr 2025: -1.40%+10.5%Positive MonthMay 2025: +10.53%+7.4%Positive MonthJun 2025: +7.36%+0.2%Neutral MonthJul 2025: +0.24%-5.1%Negative MonthAug 2025: -5.07%+3.1%Positive MonthSep 2025: +3.06%+9.3%Positive MonthOct 2025: +9.26%-16.6%Negative MonthNov 2025: -16.63%-3.2%Negative MonthDec 2025: -3.24%
2024β€”+11.9%Positive MonthFeb 2024: +11.88%-1.5%Neutral MonthMar 2024: -1.45%+0.9%Neutral MonthApr 2024: +0.90%-3.6%Negative MonthMay 2024: -3.64%+12.2%Positive MonthJun 2024: +12.17%+8.7%Positive MonthJul 2024: +8.68%-1.6%Neutral MonthAug 2024: -1.57%+11.8%Positive MonthSep 2024: +11.83%-6.2%Negative MonthOct 2024: -6.20%-4.0%Negative MonthNov 2024: -4.04%-2.6%Negative MonthDec 2024: -2.65%
AvgΒ±SD-6.8%Β±6.4%-5.6%Β±13.7%-6.9%Β±9.2%+5.3%Β±7.8%+5.0%Β±6.2%+5.9%Β±5.9%+1.3%Β±5.6%-3.3%Β±1.8%+7.4%Β±4.4%+1.5%Β±7.7%-10.3%Β±6.3%-2.9%Β±0.3%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 3 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 0.755x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή151.00 Crβ–² 39.8%
EBITDA Growthβ€”
Net Profitβ‚Ή33.00 Crβ–² 73.7%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 122.2%
Revenue CAGR 5Y11.7%
EBITDA CAGR 5Y-9.2%
Net Profit CAGR 5Y-12.5%
NP Growth 1Y73.7%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή151.00 Crβ€”β‚Ή33.00 Crβ€”β€”14.4%39.8%73.7%
Mar 2024β‚Ή108.00 Crβ€”β‚Ή19.00 Crβ€”β€”8.8%68.8%11.8%
Mar 2023β‚Ή64.00 Crβ€”β‚Ή17.00 Crβ€”β€”10.2%16.4%-5.6%
Mar 2022β‚Ή55.00 Crβ€”β‚Ή18.00 Crβ€”β€”10.8%1.9%-48.6%
Mar 2021β‚Ή54.00 Crβ€”β‚Ή35.00 Crβ€”β€”21.3%-12.9%-5.4%
Mar 2020β‚Ή62.00 Crβ€”β‚Ή37.00 Crβ€”β€”48.7%17.0%825.0%
Mar 2019β‚Ή53.00 Crβ€”β‚Ή4.00 Crβ€”β€”5.1%β€”β€”

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales5362545564108151181
Total Expenses27274241607191114
EBIT / Operating Profit253512133385967
OPM %48%56%22%25%5%35%39%37%
Other Income-1125451422-188
Finance Costs01300043
Depreciation & Amortisation6101186121920
Profit Before Tax849431819264552
Tax %49%24%18%-2%12%24%25%-
Net Profit / PAT437351817193340
EPS (β‚Ή)1,127.4210,246.549,413.982.692.412.774.715.68
Dividend Payout %0%0%0%70%78%90%0%-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Medi Assist Healthcare Services Limitedthis co.β‚Ή3.31 K Crβ‚Ή151.00 Cr82.7012.0089.0139.8%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Medi Assist Healthcare Services Limited and the metrics that matter.

Browse the full Equiscale Academy